Beijing Scitop Bio Tech Co Ltd (300858) — Cash Flow-to-Debt Ratio
Beijing Scitop Bio Tech Co Ltd (300858) has a Cash Flow-to-Debt Ratio of 0.39x as of September 2025, meaning its operating cash flow of CN¥44.72 Million could theoretically repay 0% of its total liabilities (CN¥114.58 Million) in one year. Check Beijing Scitop Bio Tech Co Ltd (300858) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Beijing Scitop Bio Tech Co Ltd Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Beijing Scitop Bio Tech Co Ltd across 11 annual periods. Also explore Beijing Scitop Bio Tech Co Ltd total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Beijing Scitop Bio Tech Co Ltd (2015–2025)
Year-by-year debt coverage analysis for Beijing Scitop Bio Tech Co Ltd. For market capitalisation and broader financial context, see market cap of Beijing Scitop Bio Tech Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.70x | CN¥123.44 Million | CN¥176.08 Million | ▼ -37.8% |
| 2024 | 1.13x | CN¥142.11 Million | CN¥126.03 Million | ▼ -19.0% |
| 2023 | 1.39x | CN¥107.27 Million | CN¥77.10 Million | ▼ -11.9% |
| 2022 | 1.58x | CN¥148.46 Million | CN¥93.99 Million | ▲ +5.0% |
| 2021 | 1.50x | CN¥110.27 Million | CN¥73.33 Million | ▲ +50.3% |
| 2020 | 1.00x | CN¥66.67 Million | CN¥66.66 Million | ▼ -32.7% |
| 2019 | 1.49x | CN¥98.27 Million | CN¥66.14 Million | ▲ +19.3% |
| 2018 | 1.25x | CN¥89.55 Million | CN¥71.91 Million | ▼ -16.5% |
| 2017 | 1.49x | CN¥84.00 Million | CN¥56.30 Million | ▲ +226.8% |
| 2016 | 0.46x | CN¥32.73 Million | CN¥71.69 Million | ▲ +2142.4% |
| 2015 | 0.02x | CN¥2.69 Million | CN¥131.89 Million | — |